跳至主要内容
临床试验/NCT06199128
NCT06199128已完成不适用

Evaluation of the Efficacy and Safety of the Local Treatment of Carboxymethyl Beta-glucan and Polycarbophil in Patients With Normal Cytology/ASCUS/LSIL (CIN1) With HPV+ PCR Determination

Uriach Consumer Healthcare5 个研究点 分布在 1 个国家目标入组 533 人开始时间: 2022年9月22日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
533
试验地点
5
主要终点
Evolution in the total or partial negativization of high-risk HPV infection in women with or without cytological alterations upon local treatment with carboxymethyl-β-glucan and polycarbophil.

研究概览

简要总结

Prospective, Controlled, Multicentre, Real Clinical Practice Study. Effectiveness of Carboxymethyl β-Glucan treatment in high-risk HPV+ patients

详细描述

To evaluate the effectiveness of local treatment with carboxymethyl-b-glucan and polycarbophil on the clearance time of human papillomavirus (HPV), as well as on the normalisation of cytological alterations identified at study inclusion.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
25 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Evolution in the total or partial negativization of high-risk HPV infection in women with or without cytological alterations upon local treatment with carboxymethyl-β-glucan and polycarbophil.

时间窗: 6 months

Evaluation of the total or partial negativization of HPV by HPV PCR test with genotype

次要结局

  • Normalization rate of abnormal colposcopy(6 Months)
  • Determine the effect of local treatment with carboxymethyl - β-glucan and polycarbophil on the total negativization rate of HPV(6 Months)
  • Change in the incidence of cytological alterations upon local treatment with carboxymethyl - β-glucan and polycarbophil during the follow-up time(6 Months)

研究者

发起方
Uriach Consumer Healthcare
申办方类型
Industry
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验